Streetbeat News

Products Services

BMR

NVDA

ORCL

Beamr Imaging Ltd. (NASDAQ:BMR) will demonstrate optimized 3D design video rendering using Oracle Cloud Infrastructure (OCI) and Nvidia accelerated computing at SIGGRAPH 2024. The demonstration will showcase reducing large video files to one-fourth of their original size.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:50 am

BLK

BTCUSD

ETHUSD

Kamala Harris is not favored by the crypto community, while Donald Trump is seen as a pro-crypto candidate. Trump attended the Bitcoin Conference and expressed support for Bitcoin and the crypto market. The SEC has softened its stance on crypto, and new Ethereum ETFs have been launched. Bitcoin is trading above key moving averages, indicating bullish sentiment.

Portfolio Pulse from Kenneth Rapoza

July 29, 2024 | 11:48 am

ZVSA

University of Miami researchers have published findings on ZyVersa Therapeutics' ASC Inhibitor, showing its potential as a biomarker for early cognitive decline detection in older adults.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:47 am

VERO

Venus Concept shares are trading higher after the company received a medical device license from Health Canada to market its Venus Bliss MAX system.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:34 am

AMST

Amesite Inc. (NASDAQ:AMST) announced that its NurseMagic app has seen an 830% user growth nationwide, reaching all 50 U.S. states and six nations within eight weeks of its public launch. The app is being used by a wide range of healthcare professionals for documentation, training, and patient communication, including translation services.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:34 am

ARQT

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) has launched ZORYVE cream for the treatment of mild to moderate atopic dermatitis in the U.S. The cream is steroid-free, provides rapid disease clearance, and is suitable for adults and children aged 6 and above.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:32 am

VERO

Venus Concept has received a medical device license from Health Canada to market its Venus Bliss MAX system.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:32 am

BITF

CLSK

COIN

HIVE

HUT

MARA

MSTR

RIOT

Shares of crypto-linked stocks are trading higher as Bitcoin rises following Donald Trump's advocacy for a strategic national crypto stockpile.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:21 am

TLRY

Tilray Brands announced that its subsidiary, Aphria RX, has received a trading license to sell and distribute medical cannabis products in Germany. This license allows Aphria RX to supply pharmacies, hospitals, and medical wholesalers.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:17 am

TSLA

Tesla faced a challenging week with weaker-than-expected Q2 earnings and the lowest profit margins in five years. Despite these setbacks, Morgan Stanley analyst Adam Jonas defended Tesla's stock, emphasizing the potential of its non-automotive divisions like energy, AI, and robotics. Jonas maintained a $310 price target, highlighting the record deployment of energy storage products. Other analysts had mixed reactions, with some criticizing Tesla's strategy and margins.

Portfolio Pulse from Navdeep Yadav

July 29, 2024 | 11:13 am